| Literature DB >> 22182737 |
Pilar Najarro1, Richard Angell, Kenneth Powell.
Abstract
In this review, we consider recent advances in the discovery and development of antiviral agents for respiratory syncytial virus (RSV) infections. A background to the various manifestations of human RSV infection and current treatments is provided. The technical, clinical and commercial issues surrounding the development of such antiviral agents are discussed.Entities:
Mesh：
Substances：
Year: 2012 PMID： 22182737 DOI： 10.3851/IMP1873
Source DB: PubMed Journal: Antivir Chem Chemother ISSN： 0956-3202